Status:
COMPLETED
Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
Lead Sponsor:
General Hospital Sveti Duh
Conditions:
End Stage Renal Disease
Renal Anemia
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
The two epoetins, Epoetin alfa, a well established drug to treat renal anemia and Epoetin Omega, that differs from Epoetin alfa in the sugar moiety of the molecule were compared in regard of efficacy ...
Detailed Description
The two epoetins, Epoetin alfa, a well established drug to treat renal anemia and Epoetin Omega, that differs from Epoetin alfa in the sugar moiety of the molecule were compared in regard of efficacy ...
Eligibility Criteria
Inclusion
- End stage renal disease
- Regular dialysis treatment
- Renal anemia (hemoglobin\<9.0 g/dl)
- Age \> 18 years
- Adequate iron stores (TIBC saturation \> 20%, ferritin \>200)
Exclusion
- Signs of bleeding
- Major surgery in previous 60 days
- Hemolysis
- Other causes of anemia
- Cancer
- Inflammatory diseases
Key Trial Info
Start Date :
January 1 1997
Trial Type :
INTERVENTIONAL
End Date :
April 1 1997
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00322413
Start Date
January 1 1997
End Date
April 1 1997
Last Update
July 21 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nephrology and Dialysis, General Hospital Sveti Duh
Zagreb, Croatia, 10000